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INTRODUCTION:  We  describe  here  an  unusual  presentation  of  a plasmablastic  lymphoma  in  a  patient
suffering  from  an  osteoradionecrosis  of  the jaw.
PRESENTATION  OF  CASE:  We  report  the  case  of a 64-year-old  patient  who  was  followed  up on  oncology
because  of  an  oropharyngeal  cancer  treated  by  a combined  procedure  of both  surgery  and  radio-
chemotherapy  procedure.  This  patient  developed  an  osteoradionecrosis  of the  jaw. In  the  vicinity  of
this necrotic  area  appeared  an  ulceration  which  could  evoke  a new  necrotic  area.  Given the  persistence
of  this  ulceration,  a biopsy  was  performed  which  highlighted  a plasmablastic  lymphoma  oral  localization.
DISCUSSION:  The  plasmablastic  lymphoma,  belonging  to  the  diffuse  large  B-cell  lymphoma  family,  is aead and neck oncology very aggressive  and  unusual  form  of cancer  with  poor  prognosis.  If it is found  mainly  in patients  with
positive  HIV,  in whom  it  was  ﬁrst  described,  it is  also  found  in  immunosuppressed  patients  such as
transplanted  patients  or  patients  suffering  from  leukaemia.
CONCLUSION:  Plasmablastic  lymphoma  is  a rare  and an  aggressive  pathology  in immunocompetent
patients.
©  2016  The  Authors.  Published  by Elsevier  Ltd  on  behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
We  describe here an unusual presentation of a plasmablastic
ymphoma in a patient suffering from an osteonecrosis of the jaw.
e will also discuss the diagnostic pitfalls as well as present a short
iterature review.
. Presentation of case
M.  S., 64 years old, had a primitive right oropharyngeal tumour
anked T3N1M0, for which he was treated by a surgery associated
ith radio-chemotherapy. This patient had a smoking and alco-
olism background, and a gastro oesophageal reﬂux disease.
In December 2008, he had an initial dental consultation before
adiotherapy (Fig. 1). The ﬁeld of irradiation included the whole
axillary and the bilateral posterior mandibular areas up to the
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second premolars. Consequently teeth number 37/38/47/48 were
extracted and the healing was acquired before the radiotherapy
began. A prevention of radio-induced tooth decay was instaured
with a daily local ﬂuoridation.
In May  2009, the patient came back for a routine check. He no
long wore his ﬂuoridation mouthguard. Consequently we observed
teeth decay. Furthermore, an area of bone exposition (3 mm large,
17 mm long) was  found on the mandibulary left molar area. Bone
sequestra were removed. We insisted on the necessity of teeth
brushing and daily ﬂuoride gel application. The patient came in
for regular check-ups and three months later we  noted a slow
but progressive epithelialization on the necrotic area. Due to the
remoteness of his home he was sent back to his treating dentist for
dental follow-up and prosthetic rehabilitation.
In December 2010, the patient developed a cancer recurrence
on the soft palate and right tonsil, successfully treated by a single
surgery.
In May  2011, the patient came back at the request of his radio-
therapist. As he was not compliant with oral hygiene and ﬂuoride
gel application, all the remaining teeth presented important decays.
Consequently the 21 remaining teeth were removed under gen-
eral anesthesia and Amoxicillin/Clavulanic acid (3 g per day, during
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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maxillary tuberosity. The patient was  seen with a dental panoramicFig. 1. First dental panoramic x-ray images (December 2008).
0 day) was prescribed. Postoperatively the healing was on the
ood way. Consequently the patient was sent to his treating dentist
o perform regular control.
Fig. 2. Imaging highlighting a bone necrosis. A: Second dental paPEN  ACCESS
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In October 2011, the patient presented an osteoradionecrosis
with 3 bone exposure areas: one (2 mm)  facing the lower premolar
area, one (3 mm)  on the right retromolar process and another one
on the top right molar area. A bone milling until having a bone
bleeding was performed, the patient was treated with antibiotics
(Amoxicillin/Clavulanic acid 3 g per day, during three weeks) and
local cleaning with chlorhexidine. The patient was  followed every
2 months all along the year 2012.
At each time we  noticed a very slow but favourable cicatrisation,
despite the persistence of a small bone exposure on the right tuber
maxillae (4 mm).  During the same period the patient was  exami-
nated by both his surgeon and radiotherapist, who found no clinical
or biological abnormality.
On February 2013, an asymptomatic ulceration (diameter
1.5 cm) with an erythematous border was  observed on the rightx-ray images and a cone beam witch highlighted a bone necro-
noramic x-ray images (January 2013). B: Cone beam slide.
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Fig. 5. In situ hybridation with EBER probes, presence of EBV transcript in every
F
A
BFig. 3. Aspect of the buccal ulceration.
is (Fig. 2). Due to the persistence of the ulceration, a biopsy was
erformed (Fig. 3).
The pathology results revealed a malpighian mucosa with a
ymphomatic proliferation, made of large cells, some with a plas-
ocytoid aspect, an abundant cytoplasm, eccentrically placed
uclei, hypertrophic nucleoli, and hindwings chromatin (Fig. 4). The
mmunohistochemistry review was negative for the CD 20, CD 10,
CL 2 and CD 30 cells, but found positive CD 79 cells and many
umoral positive CD 38 cells. The histological type was in favour of
 plasmablastic lymphoma. A second examination and a research of
ptsein Barr Virus were performed. In situ hybridation made with
BER probe points revealed the presence of EBV transcript in every
ymphomatics cells (Fig. 5). Considering this diagnosis, the patient
as sent to the haematologist. Unfortunately the patient died six
onths after diagnosis.
. Discussion
Hematologic malignancies include a wide range of pathologies.
mong them, the plasmablastic lymphoma, belonging to the diffuse
arge B-cell lymphoma family, is a very aggressive and unusual form
f cancer with poor prognosis [1–5].
Its oral presentation has been ﬁrst described in HIV positive
atients [4–6], but can also be found on other immunosuppression
ases (chemotherapy, leukaemia, transplantation. . .). The plas-
ablastic lymphoma preferential localization is the gum, the ﬂoor
f the mouth and the palate [3].
ig. 4. Histological analysis.
: Abnormal cells pointed by HES coloration (×400).
:  Histological coloration showing cellular abnormalities and plasmablastic cells (×20).lymphomatics cells.
It is histologically characterised by the proliferation of large
plasmablastic-like monomorphic cells with eccentrically placed
nuclei, an abundant cytoplasm and a high proliferation index [3,7].
In this case, the diagnosis of lymphoma was  done lately because
of the lack of speciﬁcity of plasmablastic presentation and because
of the presence of other oral lesions related to osteoradionecrosis
and radiotherapy adverse effects.
Indeed, the suspect lesion appeared after tooth extractions in
irradiated ﬁelds and had a similar presentation to osteoradionecro-
sis lesions: gingival inﬂammation, bone exposure and persistence
of the injury for more than few days [8].
Furthermore, normal biological and clinical check-ups did not
suggest a recurrence or a new cancer.
The diagnosis of plasmablastic lymphoma was achieved here
on biopsy and imaging and not thanks to the speciﬁcity of oral
associated lesions.
There are no standardized treatments but the main option is
chemotherapy, despite of its contested effectiveness [9].
4. Conclusion
The plasmablastic lymphoma is a rare and an aggressive pathol-
ogy in immunocompetent patients. Behind a persistant buccal
ulceration, even in a context of osteoradionecrosis in which the
ulceration preceded the bone exposition, a biopsy must be per-
formed.
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